Monthly Archive: December 2022
Wine Spectator: A New Day In Woodinville
When Chateau Ste. Michelle put its flagship Woodinville property on the market this summer, the Washington wine community was puzzled. Soon after, Gallo announced it was closing its Columbia Winery tasting room, located just across the road from Ste. Michelle. These two wineries were the cornerstone on which the bustling Woodinville wine scene was built. Continue reading →
Posted in News on December 28, 2022News Briefs for December 28, 2022
•Kentucky Owl Batch #12, Writers’ Tears Red Head, and newcomers from The Glenturret and Cedar Ridge are among the offerings featured in Whisky Advocate’s latest weekly roundup. Continue reading →
Posted in News on December 28, 2022Craft Brewing and Distilling News for December 28, 2022
•Jackson Hole, Wyoming’s Roadhouse Brewery has announced the purchase of Melvin Brewing Co. and its Alpine, Wyoming production facility and tap room for an undisclosed sum. Continue reading →
Posted in News on December 28, 2022Canadian Retail Player High Tide On A Steep Growth Curve
Canada-based cannabis operator High Tide Inc. is expanding rapidly in its home market and has big plans for the United States. In the span of 13 years, High Tide has evolved from a single-unit, two-employee cannabis store to a multi-national cannabis firm with more than 140 Canadian store locations and more than 1,400 employees, plus holdings and business ventures throughout the United States and the United Kingdom. Revenue almost doubled to C$249 million ($182m) in the nine months through July. High Tide CEO Raj Grover has ambitious growth plans for his company, which is publicly traded on the Nasdaq, Toronto (TSXV), and German (FWB) stock exchanges. SNDC recently caught up with Grover for an update. Continue reading →
Posted in News on December 27, 2022Bipartisan Congressional Group Calls On Biden To Deschedule Cannabis
Numerous members of Congress sent an emphatic letter to President Biden last week, urging him again to remove cannabis from its Schedule I designation, which places it in the category of most-dangerous drugs that lack any medical benefit. The letter was signed by high profile senators and representatives including leading cannabis reform voices like Barbara Lee, Ron Wyden, and Earl Blumenauer, along with others including Elizabeth Warren, Cory Booker, and Matt Gaetz, among others. Continue reading →
Posted in News on December 27, 2022Cannabis Briefs for December 27, 2022
•New York’s first recreational cannabis retail location will open this week, the state’s Office of Cannabis Management announced. Continue reading →
Posted in News on December 27, 2022
